Evidence map›Paper›PMID 33562601›Full record

ReviewInternational journal of molecular sciences2021

FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective.

Patrizia Pignataro, Manuela Dicarlo, Roberta Zerlotin, Chiara Zecca, Maria Teresa Dell'Abate, Cinzia Buccoliero, Giancarlo Logroscino, Silvia Colucci, Maria Grano

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Irisin Restrains Oligodendroglial Ferroptosis to Preserve White Matter After Traumatic Brain Injury via AMPK Activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Patrizia PignataroDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, 70124 Bari, Italy.
Manuela DicarloDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, 70124 Bari, Italy.
Roberta ZerlotinDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Chiara ZeccaCenter for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari, "Pia Fondazione Card G. Panico" Hospital Tricase, 73039 Lecce, Italy.
Maria Teresa Dell'AbateCenter for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari, "Pia Fondazione Card G. Panico" Hospital Tricase, 73039 Lecce, Italy.
Cinzia BuccolieroDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Giancarlo LogroscinoDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, 70124 Bari, Italy.
Silvia ColucciDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, 70124 Bari, Italy.
Maria GranoDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.ORCID 0000-0002-7121-5899
University of Bari Aldo Moro · IT

Funding

Regione Puglia D.G.R. n. 2117 of 21.11.2018 to Maria Grano and Giancarlo Logroscino
6 · The paper itself

Abstract

Irisin, the circulating peptide originating from fibronectin type III domain-containing protein 5 (FNDC5), is mainly expressed by muscle fibers under peroxisome proliferator-activated receptor gamma coactivator 1-alpha PGC1α control during exercise. In addition to several beneficial effects on health, physical activity positively affects nervous system functioning, particularly the hippocampus, resulting in amelioration of cognition impairments. Recently, FNDC5/irisin detection in hippocampal neurons and the presence of irisin in the cerebrospinal fluid opened a new intriguing chapter in irisin history. Interestingly, in the hippocampus of mice, exercise increases FNDC5 levels and upregulates brain-derived neurotrophic factor (BDNF) expression. BDNF, displaying neuroprotection and anti-inflammatory effects, is mainly produced by microglia and astrocytes. In this review, we discuss how these glial cells can morphologically and functionally switch during neuroinflammation by modulating the expression of a plethora of neuroprotective or neurotoxic factors. We also focus on studies investigating the irisin role in neurodegenerative diseases (ND). The emerging involvement of irisin as a mediator of the multiple positive effects of exercise on the brain needs further studies to better deepen this issue and the potential use in therapeutic approaches for neuroinflammation and ND.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorExerciseFibronectinsHippocampusHumansInflammationMiceModels, NeurologicalNeurodegenerative DiseasesNeuroimmunomodulationPhysical Conditioning, AnimalBrain-Derived Neurotrophic FactorFibronectinsFNDC5 protein, humanFNDC5 protein, mouseFNDC5irisinneurodegenerationneuroinflammation

Identifiers

PMID33562601
PMCPMC7915567
OpenAlexW3128158631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.